SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Biosimilars
Biosimilars
Page 2 of 2
Health
TPP trade deal: Even more bad news for biotech industry
By
Laura Lorenzetti
October 5, 2015
Finance
Hospira hit with further FDA scrutiny after $17 billion Pfizer deal
By
Laura Lorenzetti
April 8, 2015
Features
FDA approves the first biosimilar for the U.S. market
By
Laura Lorenzetti
March 6, 2015
Features
Biosimilars may one day save your life. But what are they?
By
Laura Lorenzetti
February 6, 2015
Most Popular
Economy
Markets sold off after Powell said six words investors don’t want to hear: ‘Equity prices are fairly highly valued’
By
Jim Edwards
AI
Cathie Wood says the AI race has already shrunk to the 'Big 4' key players, and it could soon drop to 2
By
Marco Quiroz-Gutierrez
Economy
Millions of Americans brace for shock as Obamacare bills could soar by 75% in 2026
By
Ashley Lutz
